Repare Therapeutics
Saint Laurent
About Repare Therapeutics
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. The company's drugs combine a proprietary high throughput gene-editing and target discovery method with high-resolution protein crystallography, computational biology and clinical informatics, enabling patients to improve cancer treatment both with single therapy and in combination with existing drugs and treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $251.7M
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2021)
- Ticker: nasdaq:RPTX
- Website: reparerx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/repare-therapeutics-49328 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.